Cigna Group
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 weeks.
- Recent price momentum is +11.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2852 U.S. stocks StockVane covers.
Valuation A
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 13.1x | Better than 72% |
| Forward P/E | 11.3x | Better than 73% |
| Price / Sales | 0.3x | Better than 96% |
| P/E vs own 5-yr range | 28th pctl | Better than 78% |
Growth B-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 15.1% | Better than 76% |
| Net income CAGR (3Y) | -3.9% | Better than 35% |
| Free cash flow CAGR (3Y) | 4.5% | Better than 44% |
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 9.0% | Better than 6% |
| Operating margin | 3.0% | Better than 29% |
| Net margin | 2.2% | Better than 33% |
| Return on equity | 14.4% | Better than 67% |
| Return on invested capital | 9.7% | Better than 67% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 9.7% | Better than 75% |
| 6-month return | 15.9% | Better than 72% |
| 12-month return (ex latest month) | -10.1% | Better than 27% |
| Distance below 52-week high | 0.1% | Better than 98% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 0.8x | Better than 13% |
| Debt to assets | 19.9% | Better than 56% |
| Interest coverage | 6.5x | Better than 63% |
| Free cash flow / net income | 140.8% | Better than 62% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 72.2% | Better than 50% |
| Upside to average target | 8.0% | Better than 22% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 295.19
- Open
- 293.72
- Day range
- 293.21 - 297.68
- Avg price
- 295.16
- Volume
- 1.86M
- Turnover
- 549.16M
- Turnover ratei
- 0.71%
- Volume ratioi
- 1.29
- Amplitudei
- 1.51%
- 52-week rangei
- 250.84 - 316.27
Valuation
- P/Ei
- 13.32
- P/E (TTM)i
- 12.22
- P/Bi
- 1.83
- EPSi
- 22.18
- Book value / shi
- 161.29
- Net profit
- 5.86B
- Net assets
- 42.62B
Share structure
- Market cap
- 78.07B
- Float capi
- 77.68B
- Shares out
- 264.24M
- Float sharesi
- 262.92M
Dividend & listing
- Div yield (TTM)i
- 2.08%
- Dividend (TTM)
- 6.14
- Listing date
- 1970-01-01
6.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-71.47M net over the window
Short interest
- Shares short
- 6.76M
- % of floati
- 2.56%
- Days to coveri
- 4.48
- As of
- 2026-10-15
Frequently asked questions
What is the current stock price of Cigna Group (CI)?
Cigna Group last traded at 295.44. The quote on this page refreshes every few seconds while US markets are open.
What is Cigna Group's market cap?
About 78.07B.
What is the P/E ratio of Cigna Group?
The trailing twelve-month P/E is 12.22, below its own 5-year average of 16.92 — toward the bottom of its historical range (24.94% percentile). See the Valuation tab for the full history.
Does Cigna Group pay a dividend?
Yes. The trailing dividend yield is 2.08%. The 2025 payout was up 7.9% from 2024. See the Dividends tab for the full payment history.
Is Cigna Group a buy according to analysts?
The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 341.18, which implies 15.5% upside from the current price. This is not investment advice.
What is Cigna Group's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Cigna Group a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-04 09:09:00 · For reference only, not investment advice and not tailored to your situation.
Cigna Group discussion 0 comments